Clinical Trials Logo

Clinical Trial Summary

This study will be a prospective randomized, double-blinded, placebo-controlled trial of patients undergoing primary hip arthroscopy for FAIS and/or labral pathology. All patients who sign the consent form will be enrolled in the study and randomized to one of the two treatment arms. Follow-up will take place at 1-month, 3-months, 6-months, and 1-year.


Clinical Trial Description

The investigators propose using standardized strength testing, serial quadriceps measurements, and MRI to assess the efficacy of BFR training in increasing muscle hypertrophy following hip arthroscopy. Investigators will perform a randomized double-blinded placebo-controlled controlled trial of patients undergoing primary hip arthroscopy. Quadriceps strength will be measured with dynamometers at 3, 6, and 12 month time points, with Biodex strength testing at 6 and 12 months, postoperatively. Additionally, standardized circumferential leg measurements to assess quadriceps hypertrophy will be performed at 1, 3, 6 and 12-month time points. Patients will also undergo a hip MRI at 6 months postoperatively to quantify muscle size and appearance about the hip joint. Patient reported outcomes including standard outcomes measures at 3, 6, and 12 months and return to work/sport data will also be collected at standard time points. Patients will also be followed longitudinally for rates of reinjury, return to work, and return to sport. This study will evaluate the efficacy of BFR therapy in the postoperative period of primary hip arthroscopy to improve muscle hypertrophy during the short-term rehabilitation period. This will be directly measured by strength testing with dynamometers and Biodex testing. Other metrics will include standard validated patient reported outcomes at 3, 6 and 12 month time points including hip disability and osteoarthritis outcome score (HOOS), Harris Hip score (HHS), visual analog scale (VAS) for pain, international hip outcome tool (iHOT-12), and Hip outcome score (HOS), and return to sport questionnaires. Standardized serial circumferential thigh measurements will also be recorded at each visit, in additional to a one time MRI at 6 months postoperatively. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04113759
Study type Interventional
Source Rush University Medical Center
Contact Carla M. Edwards, PhD
Phone 312-563-5735
Email carla_edwards@rush.edu
Status Recruiting
Phase N/A
Start date August 1, 2023
Completion date January 2026

See also
  Status Clinical Trial Phase
Recruiting NCT04094701 - Hip Arthroscopy Postoperative Opioid Demands N/A
Terminated NCT04093700 - MDR SureLock All-Suture Anchor
Enrolling by invitation NCT04278716 - Return to Play Checklist
Enrolling by invitation NCT05974423 - Randomized Trial of Narcotic vs Non-Narcotic Pain Modulation After Labrum Repair Phase 4
Active, not recruiting NCT03985839 - Safety and Performance of MICRORAPTORâ„¢ Suture Anchors in Shoulder and Hip
Not yet recruiting NCT06043791 - Applicability of 3T Shoulder MRI in Detection of Labral Pathology N/A